Second-Line Options For Poor-Risk Advanced Rcc

Second-Line Options for Poor-Risk Advanced RCC

Targeted Oncology

Second-Line Treatment Options for Advanced RCC

Targeted Oncology

Dr. Lee on Second-Line Treatment Options in RCC

Treatment Options for Intermediate/Poor-Risk RCC

Post-second-line systemic treatment for advanced RCC

Brian I. Rini, MD, FACP, considers 2nd line treatment in advanced RCC following I-O failure

What is the best second-line treatment of advanced renal cell carcinoma (RCC)?

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023

Touch Medical Media Services

Dr. Jonasch on First- and Second-line Options for Patients With RCC

Second-Line Treatment Options for RCC

GU Oncology Now

In RCC, What Is the Optimal Treatment for Intermediate/Poor-Risk Disease?

GU Oncology Now

Poor-Risk Advanced RCC: TKI Therapy & Outlook

Targeted Oncology

First- and second-line treatments for locally advanced renal cell carcinoma

Selecting Therapy for Poor-Risk Advanced RCC

Targeted Oncology

Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC

PeerView Oncology

Guidelines Based Management of Localized and Locally Advanced RCC

Grand Rounds in Urology

Selecting and Sequencing Targeted and Immunotherapy Regimens for Patients With RCC

PeerView Oncology

Surgery for Poor-Risk Advanced Renal Cell Carcinoma

Targeted Oncology

Case Based Overview: Poor-Risk Advanced Renal Cell Carcinoma

Targeted Oncology

Kidney Cancer Conference Highlights from ASCO GU 2023

Dana-Farber Cancer Institute